“The best approach is to have a significant conversation with your physician about the risks and benefits of screening. It's shared decision making,” says William… Read More »How can I figure out if prostate cancer screening will help me personally?
At the annual Research Matters conference yesterday, top scientists from the Johns Hopkins Kimmel Cancer Center and University of Maryland Greenebaum Cancer Center discussed research using… Read More »Top Maryland scientists discuss research on tracking and treating cancer
Prostate-specific antigen (PSA)-based screening for prostate cancer has received mixed reviews from different organizations, says William G. Nelson, M.D., Ph.D., director of the Johns Hopkins… Read More »What you need to know about prostate cancer screening guidelines
We've heard much about the national Cancer Moonshot led by Vice President Joe Biden aimed at galvanizing resources across the nation to speed the rate… Read More »What Is Maryland’s Plan to Curb Cancer?
Trina Taylor (Isaac) has felt God’s guidance throughout her journey with colorectal cancer. She had been out of work for over a year before she… Read More »Stronger Than Colon Cancer
***With the end of summer, we bring you a three-part series about Camp Sunrise, a place of summer fun for pediatric oncology patients at the… Read More »While pediatric cancer doctors heal the body, Camp Sunrise heals the soul
An antibody drug that targets part of the bone growth pathway can slow the growth of human osteosarcoma implanted in mice and prevent the tumor… Read More »Antibody May Provide a Strategy Against Metastatic Bone Cancer
--This post was written by freelance writer Becky Ham. A compound made from the tree’s bark shows promise against tumors spurred by the leptin hormone.… Read More »Can Magnolia Help Break the Link Between Obesity and Breast Cancer?
With recent FDA approvals of immunotherapy drugs for kidney and bladder cancer, patients now have more options to consider among their treatments. The 2016 ASCO… Read More »ASCO annual meeting features clinical trial results of immunotherapy for bladder and kidney cancer
A new immunotherapy drug -- the first in its class -- was approved by the Food and Drug Administration last week for bladder cancer. We… Read More »New immunotherapy drug approved to treat bladder cancer